Article Details

Analysts See $-0.71 EPS for Imperva, Inc. (IMPV); Portola Pharmaceuticals (PTLA) Has 0.89 ...

Retrieved on: 2018-07-24 18:18:45

Tags for this article:

Click the tags to see associated articles and topics

Analysts See $-0.71 EPS for Imperva, Inc. (IMPV); Portola Pharmaceuticals (PTLA) Has 0.89 .... View article details on hiswai:

Excerpt

<div>... 12/04/2018 – <b>Sequoia Capital's</b> Raanan launches cyber-focused fund; 15/05/2018 – ELLIOTT REDUCED IMPV IN 1Q: 13F; 08/05/2018 – Imperva ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up